Oncothyreon (ONTY)
Create an AlertOncothyreon EBITDA TTM
Oncothyreon EBITDA TTM Chart
View EBITDA TTM for ONTY.
Start Your YCharts Pro Gold Membership.
Oncothyreon Historical EBITDA TTM Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | Go Pro |
| Dec. 31, 2012 | Go Pro |
| Sept. 30, 2012 | Go Pro |
| June 30, 2012 | Go Pro |
| March 31, 2012 | Go Pro |
| Dec. 31, 2011 | Go Pro |
| Sept. 30, 2011 | Go Pro |
| June 30, 2011 | Go Pro |
| March 31, 2011 | Go Pro |
| Dec. 31, 2010 | Go Pro |
| Sept. 30, 2010 | Go Pro |
| June 30, 2010 | Go Pro |
| March 31, 2010 | Go Pro |
| Dec. 31, 2009 | Go Pro |
| Sept. 30, 2009 | Go Pro |
| June 30, 2009 | Go Pro |
| March 31, 2009 | Go Pro |
| Dec. 31, 2008 | Go Pro |
| Sept. 30, 2008 | Go Pro |
| June 30, 2008 | Go Pro |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About EBITDA (TTM)
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization. EBITDA (TTM) is the sum of the last four quarters of EBITDA.
Investors often use EBITDA as a starting point for discounted cash flow analysis or to observe the performance of a business separately from its capital structure (debt vs equity financing structure).
Though EBITDA does form an excellent basis for cash flow analysis, some investors argue that it is a misleading measure since depreciation expenses are a real cost - old property, plant and equipment must eventually be replaced if a business plans to continue operations using those assets.
Learn More
View EBITDA TTM for ONTY.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
ONTY EBITDA TTM Benchmarks
| Companies | |
|---|---|
| Array BioPharma | Go Pro |
| Ariad Pharmaceuticals | Go Pro |
| Infinity Pharmaceuticals | Go Pro |
ONTY EBITDA TTM Rankings
| Overall |
56th percentile 7368 of 16773 |
| Sector |
57th percentile 603 of 1408 in Healthcare |
| Industry |
70th percentile 134 of 453 in Biotechnology |
